Sex hormone-binding globulin and type 2 diabetes mellitus

Trends in Endocrinology and Metabolism

Volumn 23, Issue 1, 2012, Pages 32-40

  Le, Trang N ^a   Nestler, John E ^a   Strauss, Jerome F ^a   Wickham, Edmond P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DIAZOXIDE; ESTRADIOL; ESTROGEN; HEMOGLOBIN A1C; INSULIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ALLELE; BODY MASS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; ESTROGEN THERAPY; GENETIC PREDISPOSITION; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; TRANSCRIPTION REGULATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; SEX HORMONE-BINDING GLOBULIN;

EID: 84855217106     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.09.005     Document Type: Review

References (93)

1. Wild S., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Defronzo R.A. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
3. Poretsky L., et al. The insulin-related ovarian regulatory system in health and disease. Endocr. Rev. 1999, 20:535-582.
4. Andersson B., et al. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994, 17:405-411.
5. Petra P.H. The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function. J. Steroid Biochem. Mol. Biol. 1991, 40:735-753.
6. Anderson D.C. Sex-hormone-binding globulin. Clin. Endocrinol. (Oxf.) 1974, 3:69-96.
7. Mendel C.M. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J. Androl. 1992, 13:107-116.
8. Rosner W., et al. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem. Mol. Biol. 1999, 69:481-485.
9. Hammes A., et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005, 122:751-762.
10. Porto C.S., et al. Receptors for androgen-binding proteins: internalization and intracellular signalling. J. Steroid Biochem. Mol. Biol. 1995, 53:561-565.
11. Fortunati N., et al. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells. J. Steroid Biochem. Mol. Biol. 1999, 69:473-479.
12. Hryb D.J., et al. Sex hormone-binding globulin in the human prostate is locally synthesized and may act as an autocrine/paracrine effector. J. Biol. Chem. 2002, 277:26618-26622.
13. Plymate S.R., et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab. 1988, 67:460-464.
14. Nestler J.E., et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1991, 72:83-89.
15. Selva D.M., et al. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J. Clin. Invest. 2007, 117:3979-3987.
16. Plymate S.R., et al. Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin. Steroids 1988, 52:339-340.
17. Peter A., et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010, 59:3167-3173.
18. Nestler J.E. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance?. J. Clin. Endocrinol. Metab. 1993, 76:273-274.
19. Lindstedt G., et al. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991, 40:123-128.
20. Haffner S.M., et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 1996, 143:889-897.
21. Ring H.Z., et al. Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J. Clin. Endocrinol. Metab. 2005, 90:3653-3658.
22. Meikle A.W., et al. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins. Prostate 1997, 33:105-111.
23. Jaquish C.E., et al. Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study. Metabolism 1997, 46:988-991.
24. Perry J.R., et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum. Mol. Genet. 2010, 19:535-544.
25. Ding E.L., et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 2009, 361:1152-1163.
26. Ding E.L., et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299.
27. Rincon J., et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 1996, 45:615-621.
28. Lin H.Y., et al. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 2005, 54:1717-1725.
29. Liu S., et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009, 58:2292-2302.
30. Le May C., et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9232-9237.
31. Tiano J.P., et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. J. Clin. Invest. 2011, 121:3331-3342.
32. Kanaya A.M., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2003, 138:1-9.
33. de Lauzon-Guillain B., et al. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort. Diabetologia 2009, 52:2092-2100.
34. Shifren J.L., et al. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J. Clin. Endocrinol. Metab. 2008, 93:1702-1710.
35. Brand J.S., et al. Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men. Clin. Endocrinol. (Oxf.) 2011, 74:572-578.
36. Page-Wilson G., et al. Interrelation between sex hormones and plasma sex hormone-binding globulin and hemoglobin A1c in healthy postmenopausal women. Metab Syndr. Relat Disord. 2009, 7:249-254.
37. Lakshman K.M., et al. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J. Gerontol. A: Biol. Sci. Med. Sci. 2010, 65:503-509.
38. Vikan T., et al. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur. J. Endocrinol. 2010, 162:747-754.
39. Kalyani R.R., et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J. Clin. Endocrinol. Metab. 2009, 94:4127-4135.
40. Bonnet F., et al. Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Eur. J. Endocrinol. 2009, 161:81-85.
41. Basu R., et al. Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care 2007, 30:1972-1978.
42. Cameron A.J., et al. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab Clin. North Am. 2004, 33:351-375.
43. Morrison J.A., et al. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007, 120:340-345.
44. Morrison J.A., et al. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J. Pediatr. 2008, 152:201-206.
45. Agirbasli M., et al. Sex hormones and metabolic syndrome in children and adolescents. Metabolism 2009, 58:1256-1262.
46. Glueck C.J., et al. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. J. Pediatr. 2011, 159:308-313.
47. Li C., et al. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010, 33:1618-1624.
48. Bogaert V., et al. Heritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings. Clin. Endocrinol. (Oxf.) 2008, 69:129-135.
49. An P., et al. Population differences in the pattern of familial aggregation for sex hormone-binding globulin and its response to exercise training: the HERITAGE Family Study. Am. J. Hum. Biol. 2001, 13:832-837.
50. Ahn J., et al. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Hum. Mol. Genet. 2009, 18:3749-3757.
51. Berube D., et al. Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12-p13). Cytogenet. Cell Genet. 1990, 54:65-67.
52. Hammond G.L., et al. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol. Endocrinol. 1989, 3:1869-1876.
53. Avvakumov G.V., et al. Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer. J. Biol. Chem. 2001, 276:34453-34457.
54. Grishkovskaya I., et al. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J. 2000, 19:504-512.
55. Avvakumov G.V., Strel'chyonok O.A. Methylation analysis in glycoprotein chemistry: a comparative study of the carbohydrate structures of three hormone-binding glycoproteins from human serum. Carbohydr. Res. 1985, 138:91-98.
56. Walsh K.A., et al. Amino acid sequence of the sex steroid binding protein of human blood plasma. Biochemistry 1986, 25:7584-7590.
57. Avvakumov G.V., et al. Study of the carbohydrate moiety of human serum sex hormone-binding globulin. Biochim. Biophys. Acta. 1983, 760:104-110.
58. Petra P.H., et al. Complete enzymatic deglycosylation of native sex steroid-binding protein (SBP or SHBG) of human and rabbit plasma: effect on the steroid-binding activity. Protein Sci. 1992, 1:902-909.
59. Strel'chyonok O.A., Avvakumov G.V. Specific steroid-binding glycoproteins of human blood plasma: novel data on their structure and function. J. Steroid Biochem. 1990, 35:519-534.
60. Avvakumov G.V., et al. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol. Cell Endocrinol. 2010, 316:13-23.
61. Rosner W., et al. Androgens, estrogens, and second messengers. Steroids 1998, 63:278-281.
62. Rosner W. Sex steroids and the free hormone hypothesis. Cell 2006, 124:455-456.
63. Xita N., Tsatsoulis A. Genetic variants of sex hormone-binding globulin and their biological consequences. Mol. Cell Endocrinol. 2010, 316:60-65.
64. Hogeveen K.N., et al. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J. Clin. Invest. 2002, 109:973-981.
65. Khan M.S., et al. Delineation and synthesis of the membrane receptor-binding domain of sex hormone-binding globulin. J. Biol. Chem. 1990, 265:18362-18365.
66. Khan M.S., et al. Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line. J. Clin. Endocrinol. Metab. 1981, 53:448-449.
67. Moore K.H., et al. Sex hormone binding globulin mRNA in human breast cancer: detection in cell lines and tumor samples. J. Steroid Biochem. Mol. Biol. 1996, 59:297-304.
68. Herbert Z., et al. Identification of sex hormone-binding globulin in the human hypothalamus. Neuroendocrinology 2005, 81:287-293.
69. Forges T., et al. Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells. Mol. Cell Endocrinol. 2004, 219:61-68.
70. Larrea F., et al. Evidence that human placenta is a site of sex hormone-binding globulin gene expression. J. Steroid Biochem. Mol. Biol. 1993, 46:497-505.
71. Misao R., et al. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects. Gynecol. Endocrinol. 1995, 9:317-323.
72. Nakhla A.M., et al. Human sex hormone-binding globulin gene expression - multiple promoters and complex alternative splicing. BMC. Mol. Biol. 2009, 10:37.
73. Gershagen S., et al. Characterization of the human sex hormone binding globulin (SHBG) gene and demonstration of two transcripts in both liver and testis. Nucleic Acids Res. 1989, 17:9245-9258.
74. Power S.G., et al. Molecular analyses of a human sex hormone-binding globulin variant: evidence for an additional carbohydrate chain. J. Clin. Endocrinol. Metab. 1992, 75:1066-1070.
75. Cousin P., et al. Human variant sex hormone-binding globulin (SHBG) with an additional carbohydrate chain has a reduced clearance rate in rabbit. J. Clin. Endocrinol. Metab. 1998, 83:235-240.
76. Hardy D.O., et al. Molecular characterization of a genetic variant of the steroid hormone-binding globulin gene in heterozygous subjects. J. Clin. Endocrinol. Metab. 1995, 80:1253-1256.
77. Hogeveen K.N., et al. Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence. J. Biol. Chem. 2001, 276:36383-36390.
78. Lee I.R., et al. Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens. J. Clin. Endocrinol. Metab. 1987, 64:825-831.
79. Rosner W., et al. Hormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell line. J. Clin. Endocrinol. Metab. 1984, 59:806-808.
80. Haffner S.M., et al. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 1988, 37:683-688.
81. Crave J.C., et al. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J. Clin. Endocrinol. Metab. 1995, 80:1283-1289.
82. Nanda S., et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat. Diag. 2011, 31:135-141.
83. Moran L.J., et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 2010, 16:347-363.
84. Wickham E.P., et al. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab 2011, 96:E719-E727.
85. Bendlova B., et al. Role of D327N sex hormone-binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome. J. Steroid Biochem. Mol. Biol. 2007, 104:68-74.
86. Xita N., et al. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J. Clin. Endocrinol. Metab. 2003, 88:5976-5980.
87. Utzschneider K.M., Kahn S.E. Review. The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab 2006, 91:4753-4761.
88. Vassilatou E., et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum. Reprod. 2010, 25:212-220.
89. Laaksonen D.E., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004, 27:1036-1041.
90. Stellato R.K., et al. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000, 23:490-494.
91. Okubo M., et al. Association of sex hormone-binding globulin and insulin resistance among Japanese-American subjects. Diabetes Res. Clin. Pract. 2000, 47:71-75.
92. Tibblin G., et al. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996, 45:1605-1609.
93. Haffner S.M., et al. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J. Clin. Endocrinol. Metab 1993, 77:56-60.